Paper Review Records
All Paper Review Records
25 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
105
days
Single-cell mapping of thymus-dependent naïve t-cell regeneration reveals CD61-associated states after hematopoietic stem cell transplantation
Authors
Fangqing Zhang; Xinya Jiang; Shuang Fan; Bixia Wang; Zhigui Wu; Jingrui Zhou; Qi Zhang; Zhiyu Zhang; Jianing Tang; Zheng-Li Xu; Yu Wang; Xiao-Jun Huang; Huidong GuoShow moreShow less
Affiliations
1. Beijing Key Laboratory of Cell and Gene Therapy for Hematologic Malignancies, Collaborative Innovation Center of Hematology, National Clinical Research Center for Hematologic Disease, Peking University People’s Hospital, Peking University Institute of Hematology, Peking University, Beijing, China; 2. Peking-Tsinghua Center for Life Sciences, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, ChinaShow moreShow less
105
days
Novel agents and evolving strategies in Waldenström macroglobulinemia: clinical trial updates from ASH 2025
Authors
Yujing Liang; Xinyi Deng; Ziwen Wang; Chuanmiao Xie; Lie Zheng; He Huang; Shaohan Yin; Huageng HuangShow moreShow less
Affiliations
1. Department of Radiology, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China; 2. Department of Dermatology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, P.R. China; 3. Department of Pediatric Oncology, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China; 4. Department of Medical Oncology, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, P. R. ChinaShow moreShow less
235
days
Spatial multi omic profiling maps hypoxia-driven pro-fibrotic SPP1 + macrophages underpinning immune escape and TACE resistance in hepatocellular carcinoma
Authors
Fansen Ji; Hao Chen; Boyang Wu; Ying Xiao; Jiawei Zhang; Jianghui Yang; Weihua Yan; Xiaojuan Wang; Bingjun Tang; Huan Li; Siyu Wu; Quan He; Hao Liu; Haoming Xia; Xinquan Liu; Yibo Gao; Pengfei Wang; Shizhong Yang; Jiahong DongShow moreShow less
Affiliations
1. Tsinghua-Peking Center for Life Sciences, Beijing, China; 2. Hepatopancreatobiliary Center, Key Laboratory of Digital Intelligence Hepatology (Ministry of Education), School of Clinical Medicine, Tsinghua Medicine, Beijing Tsinghua Changgung Hospital, Tsinghua University, Beijing, China; 3. Department of Pathology, Beijing Tsinghua Changgung Hospital, Tsinghua University, Beijing, China; 4. Health Management Center, Beijing Jishuitan Hospital, Capital Medical University, Beijing, China; 5. Cold Spring Biotech Corp., Beijing, China; 6. Institute for Organ Transplant and Bionic Medicine, Beijing Key Laboratory of Liver Transplantation and Bionic Manufacturing, Tsinghua University, Beijing, China; 7. Central Laboratory and Shenzhen Key Laboratory of Epigenetics and Precision Medicine for Cancers, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital and Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, ChinaShow moreShow less
68
days
Long-term extended-interval teclistamab and talquetamab dosing without step-up dosing in previously treated multiple myeloma
Authors
Callee Brooks; Leslie Mader; Kathryn Kennedy; Phyu Thin Naing; Salyka Sengsayadeth; Bhagirathbhai Dholaria; Adetola Kassim; Sarah Profitt; Muhamed BaljevicShow moreShow less
Affiliations
1. Department of Pharmacy, Vanderbilt University Medical Center, Nashville, USA; 2. Department of Medicine, Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, USA; 3. Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, USAShow moreShow less
117
days
Sequential therapy with decitabine and an XPO-1 inhibitor followed by allogeneic hematopoietic stem cell transplantation in MDS with biallelic TP53 inactivation patients : a preliminary case series
Authors
Yanling Ren; Wei Lang; Yu Xu; Chen Mei; Xianbo Huang; Shasha Wang; Jiejing Qian; Hongyan TongShow moreShow less
Affiliations
1. Department of Hematology, The First Affiliated Hospital, school of Medicine, Zhejiang University, Hangzhou, ChinaShow moreShow less
163
days
AAV-delivered miRNA-gated Cre circuits enable programmable gene activation in AFP-active liver tumor models
Authors
Xiaoting Zhang; Congcong Cao; Zeqi Huang; Dongde Wu; Tao Yin; Yuchen Liu; Jian Shen; Aolin Li; Shuofei Yang; Lei NieShow moreShow less
Affiliations
1. Central Laboratory, Shenzhen Bao’an District Songgang People’s Hospital, Shenzhen, China; 2. Shenzhen Bao’an medical college of Guangdong Pharmaceutical University, Shenzhen, China; 3. Hubei Shizhen Laboratory, School of Basic Medical Sciences, Hubei University of Chinese Medicine, Wuhan, China; 4. Shenzhen Institute of Translational Medicine, Shenzhen Second People’s Hospital, Health Science Center, The First Affiliated Hospital of Shenzhen University, Shenzhen University, Shenzhen, China; 5. Department of Hepatobiliary and Pancreatic Surgery, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; 6. Department of Urology, Shenzhen Second People’s Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen, China; 7. Department of Vascular Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, ChinaShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review62 days
Median65 days